CTLA4 inhibiting antibodies (Noth Coast Biologics)

N/A

Report date: 2025/03/18 18:14:01

Base Information

Drug NameCTLA4 inhibiting antibodies (Noth Coast Biologics)

Drug Alias NameCTLA4 targeting humanized antibodies (North Coast Biologics)cytotoxic T-lymphocyte antigen 4 inhibiting antibodies (North Coast Biologics)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors

TargetsCytotoxic T-Lymphocyte-Associated Antigen 4

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNorth Coast Biologics LLC

China Registration ClassN/A

Develop Information

Active CompaniesNorth Coast Biologics LLC

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A